等待开盘 11-18 09:30:00 美东时间
+0.300
+13.95%
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.21) by 76.19 percent. This is a 81.48 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $1.159 mil...
11-17 16:38
中期选举投票开启!或影响美债、通胀与AI;苹果盘前跌逾4%,毛利率指引远逊预期;存储、光通信股盘前反弹,闪迪升逾4%,迈威尔升近3%;AMD、超微电脑盘后放榜>>
11-03 21:27
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG cut the price target for Acumen Pharmaceuticals Inc (NASDAQ:ABOS) from $8 to $1. BTIG analyst Thomas Shra...
11-02 21:26
Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and raises the price target from $50 to $51.
11-02 17:48
In a report released yesterday, Thomas Shrader from BTIG maintained a Buy ratin...
11-02 09:35
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从49美元升至50美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从24美元升至25美元
10-02 08:33
Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and raises the price target from $49 to $50.
10-01 17:21